Pharmacokinetics, distribution, and excretion of sodium oligomannate, a recently approved anti-Alzheimer's disease drug in China

The National Medical Products Administration has authorized sodium oligomannate for treating mild-to-moderate Alzheimer's disease. In this study, an LC-MS/MS method was developed and validated to quantitate sodium oligomannate in different biomatrices. The plasma pharmacokinetics, tissue distributio...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Jiaojiao Lu, Qiongqun Pan, Jieqiang Zhou, Yan Weng, Kaili Chen, Lv Shi, Guanxiu Zhu, Chunlin Chen, Liang Li, Meiyu Geng, Zhenqing Zhang
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Elsevier 2022-02-01
سلاسل:	Journal of Pharmaceutical Analysis
الموضوعات:	Sodium oligomannate Alzheimer's disease Pharmacokinetics LC-MS/MS Oligosaccharide
الوصول للمادة أونلاين:	http://www.sciencedirect.com/science/article/pii/S2095177921000617
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!